The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

14 Sep 2016 15:38

RNS Number : 8630J
Microsaic Systems plc
14 September 2016
 

14 September 2016

Microsaic Systems plc

 

("Microsaic", "Microsaic Systems" or the "Company")

 

Grant of options

 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that further to the announcement and circular dated 26 August 2016, which contained details of a proposed share option scheme, the Company has today granted options ("Options") over 6,200,000 ordinary shares in the Company ("Ordinary Shares"), representing approximately 3.42 per cent. of the issued share capital of the Company. 

 

Certain of the Options have been granted to executive directors as detailed below. No Options were granted to non-executive directors.

 

Director

Position

Number of Options Granted

Exercise price of these Options

Total options Held

Jim Ramage

Chief Executive Officer

1,000,000

5 pence

1,500,000

Glenn Tracey

Chief Operating Officer

1,000,000

5 pence

1,300,000

Bevan Metcalf

Finance Director

1,000,000

5 pence

1,120,000

 

The 3,000,000 options granted to executive directors ("Management Options") were granted under Microsaic's Enterprise Management Incentive (EMI) Scheme and have an exercise price of 5 pence per Ordinary Share, being the issue price of the Ordinary Shares issued pursuant to the Placing on 13 September 2016 (the "Placing Price"). The Management Options will vest in approximately three equal tranches subject to performance criteria linked to the share price appreciation against the Placing Price of 5 pence (2 x Placing Price, 3 x Placing Price and 4 x Placing Price) and time based criteria vesting on the second anniversary of the date of grant.

 

The balance of 3,200,000 options were granted to all other employees of the Company ("Employee Options") under Microsaic's EMI Scheme which also have an exercise price of 5 pence per ordinary share, being the Placing Price. The Employee Options vest on the third anniversary of the date of grant and are not subject to performance criteria.

 

Following the grant of the Options, the total number of Ordinary Shares outstanding under share incentive scheme arrangements is 7,897,200, representing 4.35 per cent. of the Company's issued share capital.

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide additional detail.

 

Enquiries:

Microsaic Systems plc

Jim Ramage, CEO

Bevan Metcalf, FD

+44 (0) 1483 751577

 

N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson

Liz Yong

 

 

+44 (0)20 7496 3000

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Marine Perrier

+44 (0)20 7282 2948/1068

 

About Microsaic Systems

 

Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.

 

Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.

 

The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.

 

The Microsaic 4000 MiD®, single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).

 

www.microsaic.com

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

J C Ramage

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - CEO

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Microsaic Systems plc

b)

 

LEI

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Share options over ordinary shares of 0.25p each

 

GB00B547ZY09

 

b)

 

Nature of the transaction

 

Award of share options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5 pence

 

1,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

Not applicable

 

 

e)

 

Date of the transaction

 

14 September 2016

f)

 

Place of the transaction

 

Off market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

G D Tracey

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - COO

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Microsaic Systems plc

b)

 

LEI

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Share options over ordinary shares of 0.25p each

 

GB00B547ZY09

 

b)

 

Nature of the transaction

 

Award of share options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5 pence

 

1,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

Not applicable

 

 

e)

 

Date of the transaction

 

14 September 2016

f)

 

Place of the transaction

 

Off market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

B J Metcalf

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - Finance Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Microsaic Systems plc

b)

 

LEI

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Share options over ordinary shares of 0.25p each

 

GB00B547ZY09

 

b)

 

Nature of the transaction

 

Award of share options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5 pence

 

1,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

Not applicable

 

 

e)

 

Date of the transaction

 

14 September 2016

f)

 

Place of the transaction

 

Off market

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWFLLFMSEDU
Date   Source Headline
11th Aug 20209:30 amRNSForm 8.5 (EPT/RI)
10th Aug 20204:33 pmBUSForm 8.3 - Microsaic Systems
10th Aug 202010:08 amRNSForm 8.5 (EPT/RI)
7th Aug 20204:59 pmRNSForm 8.3 - Microsaic Systems PLC
7th Aug 20209:14 amRNSForm 8.5 (EPT/RI)
6th Aug 202012:07 pmRNSForm 8.5 (EPT/RI)
5th Aug 202010:04 amRNSForm 8.5 (EPT/RI)
4th Aug 20202:31 pmRNSForm 8.3 - Microsaic Systems PLC
4th Aug 202011:39 amRNSForm 8.5 (EPT/RI)
3rd Aug 20201:54 pmRNSForm 8.3 - Microsaic Systems plc
3rd Aug 202011:24 amRNSForm 8.5 (EPT/RI)
31st Jul 20204:06 pmRNSForm 8 (OPD) Microsaic Systems plc
31st Jul 20201:43 pmRNSForm 8.3 - Microsaic Systems plc
31st Jul 20209:37 amRNSForm 8.5 (EPT/RI)
31st Jul 20209:11 amRNSForm 8.3 - Microsaic Systems plc
30th Jul 20204:03 pmRNSParkwalk Advisors: Form 8.3- Microsaic Systems plc
30th Jul 202011:47 amRNSForm 8.5 (EPT/RI)
29th Jul 20205:48 pmGNWForm 8.3 - Microsaic Systems plc
29th Jul 202012:00 pmRNSForm 8.3 - Microsaic Systems plc
29th Jul 20207:00 amRNSStrategic Review and Formal Sale Process
25th Jun 20203:16 pmRNSResult of AGM
1st Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20207:00 amRNSCOVID-19 Update
9th Mar 20207:00 amRNSFinal Results
3rd Mar 20207:00 amRNSAppointment of WH Ireland as Joint Broker
26th Feb 20207:00 amRNSGlobal collaboration agreement with Axcend Corp
16th Jan 20207:00 amRNSPre-close Trading Update
16th Dec 20197:00 amRNSMicrosaic collaborates with the CPI
6th Dec 20194:35 pmRNSPrice Monitoring Extension
5th Dec 20199:05 amRNSSecond Price Monitoring Extn
5th Dec 20199:00 amRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSExclusive Japan Distribution Agreement
13th Nov 20194:41 pmRNSSecond Price Monitoring Extn
13th Nov 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.